nimacimab glp-1 news Obesity — Skye Bioscience GLP-1 Pipeline Update: August 2025
Description
Other studies using rodents or primates with immunofluorescent reporter GLP-1Rs verify the expression of GLP-1Rs by pyramidal (glutamergic), GABAergic and catecholaminergic neurons in feeding, energy homeostasis, fear, stress, motivation/reward, learning plus memory as well as Alzheimers disease (AD) and Parkinsons Disease (PD)-associated key brain areas, such as the hippocampus, hypothalamus, cortex, striatum, amygdala, SNpc, or ventral tegmental area (VTA) (Cork et al., 2015
She discussed how the national conversation funneled a breakthrough class of medications into a debate about thinness and body image, and in the process obscured what they actually do
Lean mass sparing in resistance-trained athletes during caloric restriction: the role of resistance training volume
Sleep Deprivation: Effects on Weight Loss and Weight Loss Maintenance
[DOI] [PubMed] [Google Scholar] 905.Gadde K.M., Allison D.B., Ryan D.H., Peterson C.A., Troupin B., Schwiers M.L
Gastric Effects: Higher systemic drug levels from injections produce stronger effects on stomach emptying and satiety signaling
